CDK9-IN-12 is a highly selective CDK9 inhibitor, which is commonly used in leukemia research to regulate oncogene expression, inhibit oncogenic proliferation, and induce apoptosis by targeting CDK9-dependent transcription processes.
Molecular Weight:
378.86
Purity:
98.93%
CAS Number:
[1942843-54-0]
Formula:
C21H19ClN4O
Target:
CDK
T39354
T39354
* VAT and and shipping costs not included. Errors and price changes excepted
